CE, MOC, & Certificates

This three-day meeting cosponsored by the American Society of Clinical Oncology (ASCO) and the Society for the Immunotherapy of Cancer (SITC) will focus on clinical and translational research in immuno-oncology and the implications for patient care. The symposium will address the high level of need for up-to-date information in a rapidly changing field as well as for clinical education in an area in which all aspects of care are fundamentally different from traditional therapies. Expert faculty will contextualize the latest science for clinical application, and the program will include formal opportunities for networking, discussion and interaction.

New for 2017, attendees need their username and password to access the CE Portal. If you do not know your username or password, you may use your email address to retrieve them. If you do not know the email address associated with your account, please contact

  • Onsite: ASCO staff at the Tech Help Desk in the Posters, Exhibits, and Food Service Room or at the Registration and Customer Service Desk.
  • Off-site: ASCO Customer Service from 8:30 AM - 5:00 PM (ET) at customerservice@asco.org, 888-282-2552 or 703-299-0158.
Accreditation and Designation Statement

In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AMA Credit Designation Statement – Physicians

The American Society of Clinical Oncology designates this live activity for a maximum of 21.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other attendees may request a Certificate of Participation after submitting their session participation. Please note that all final decisions regarding certificate acceptance toward any licensure requirements will be made by the licensing organization to which the certificate is submitted.

Commercial Supporters

ASCO and the Conquer Cancer Foundation gratefully acknowledge the following companies for their support of the 2017 ASCO Immuno-Oncology Symposium:

Amgen AstraZeneca
Celgene Corporation Genentech BioOncology™
Incyte Merck & Co., Inc.
Novartis Oncology Pfizer Oncology
Prometheus Laboratories  


Educational Needs Statement

The inaugural ASCO-SITC Clinical Immuno-Oncology Symposium, co-sponsored by the American Society of Clinical Oncology (ASCO) and the Society for Immunotherapy of Cancer (SITC), offers a multidisciplinary platform for healthcare providers and clinical researchers to develop proficiency in leveraging developments in the new and emerging science of immuno-oncology. This field is constantly evolving, generating an ongoing need to provide practitioners with state of the art updates in immunotherapy. The new immunotherapies have unique toxicities that are not seen in other therapies, emphasizing the need to familiarize the oncology practitioner with the spectrum of adverse events seen with newly approved and emerging modalities.

Target Audience

This symposium is designed for physicians and researchers involved in multidisciplinary clinical cancer care including, but not limited to medical, surgical, and radiation oncologists; pathologists; radiologists; and other translational-oriented laboratory scientists; nurses, pharmacists, advanced practice providers, and other health care professionals involved in clinical cancer care and cancer research in immuno-oncology.

Learning Objectives and Competencies

Upon participation in this activity, attendees will be able to:

  • Develop strategies to select the appropriate  immunotherapeutic agents for patients
  • Integrate immunotherapy, including checkpoint blockades, vaccine therapies, and the use of immunomodulatory antibodies into the current treatment paradigm of cancer care
  • Identify and analyze the opportunities and limitations of immunotherapy as part of care plans
  • Determine where recent advances in immunotherapy and cellular therapy trials can be used to  influence clinical updates
  • Improve the prevention and management of toxicities, adverse events, and other immune-related side effects of approved immunotherapies
  • Appropriately interpret antitumor response in immunotherapy and effectively use biomarkers of response and resistance to monitor immune-based therapies

This activity was planned in the context of the following attributes:

Institute of Medicine (IOM) Competencies:

Accreditation Council for Graduate Medical Education (ACGME) Core Competencies:

  • Delivering patient-centered care;
  • Practicing evidence-based medicine;
  • Focusing on quality improvement
  • Patient Care;
  • Medical Knowledge;
  • Practice Based Learning and Improvement;
  • Systems-Based Practice


Disclaimer and Unlabeled Usage Statement

The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of the Symposium Cosponsors and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters. Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.

Available Certificates

Attendees can log in to the iPlanner or CE Portal to access any of the following certificates after noting their participation:

  • Continuing Medical Education Certificate – available for physicians who would like to receive CME credits for their participation at the Symposium
  • Certificate of Participation – all other attendees may request a Certificate of Participation after recording their session participation. Please note that all final decisions regarding certificate acceptance toward any licensure requirements will be made by the licensing organization to which the certificate is submitted.
  • Certificate of Attendance – Attendees can download a Certificate of Attendance from the Attendee Resource Center if they need a record of their attendance at the Symposium but do not require documentation for continuing education purposes. Please note that this certificate does not award any continuing education credits.

For instructions on how to claim credit and access certificates, please see the ‘Symposium Feedback and Credit Claim Instructions’ section.

Symposium Feedback and Credit Claim Instructions

Every participant is encouraged to submit a Symposium Feedback Form, provide session ratings, and access certificates for the Symposium through the iPlanner app. Your feedback is utilized by leadership to enhance programs, develop new initiatives, gauge educational impact, and plan for future meetings. 

  • To provide feedback on a specific session
    1. Download the iPlanner app
    2. Select a session by searching by time or track
    3. Select “Rate This Session” to submit feedback on each session you attend
  • To access certificates and claim credit
    1. Log in to the CE Portal using your ASCO.org username and password
    2. Select a session by searching by time or keyword
    3. Select “Claim More Credits” to claim CME credits and access your certificate
  • To give overall feedback on the meeting
    1. Submit a Symposium Feedback Form 

To receive ABIM MOC points, participants must submit their Symposium Feedback Form, available on the iPlanner and CE Portal, and claim their CME credits for the Symposium by March 27, 2017. Once both of these steps are complete, ASCO will transmit all information to ABIM on the participant’s behalf.